Association between antimicrobial consumption and clinical isolates of methicillin-resistant Staphylococcus aureus: A 14-year study

Journal of Infection and Chemotherapy

Volumn 18, Issue 1, 2012, Pages 90-95

  Nakamura, Ayako ^a   Miyake, Kazunori ^b   Misawa, Shigeki ^a   Kuno, Yutaka ^a   Horii, Takashi ^a   Hori, Satoshi ^b   Kondo, Shigemi ^b   Tabe, Yoko ^b   Ohsaka, Akimichi ^a,b  

^a JUNTENDO UNIVERSITY HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Antimicrobial consumption; MRSA; Multiple stepwise regression analysis; Lactam antimicrobials

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFMETAZOLE; CEFOTIAM; CEPHALOSPORIN DERIVATIVE; IMIPENEM; MEROPENEM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; DRUG USE; HOSPITAL BED; HUMAN; INFECTION RISK; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; RETROSPECTIVE STUDY; RISK ASSESSMENT; TERTIARY HEALTH CARE; TREATMENT DURATION;

EID: 84863450700     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-011-0302-6     Document Type: Article

References (25)

1. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;368:874-85. (Pubitemid 44308640)
2. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med. 2002;162:2229-35. (Pubitemid 35231593)
3. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-Analysis. Clin Infect Dis. 2003;36:53-9. (Pubitemid 36099097)
4. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592-8. (Pubitemid 36259564)
5. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26:166-74. (Pubitemid 40445022)
6. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46(Suppl 5):S344-9. (Pubitemid 351717321)
7. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7:629-41.
8. Deurenberg RH, Vink C, Kalenic S, Friedrich AW, Bruggeman CA, Stobberingh EE. The molecular evolution of methicillinresistant Staphylococcus aureus. Clin Microbiol Infect. 2007;13:222-35. (Pubitemid 46603352)
9. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-Analysis. J Antimicrob Chemother. 2008;61:26-38.
10. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother. 2002;49:999-1005. (Pubitemid 34692894)
11. Grundmann H, Hori S, Winter B, Tami A, Austin DJ. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis. 2002;185:481-8. (Pubitemid 34142810)
12. Crowcroft NS, Ronveaux O, Monnet DL, Mertens R. Methicillinresistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol. 1999;20:31-6.
13. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis. 2003;9:1415-22. (Pubitemid 37356215)
14. Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis. 2001;32:1044-54. (Pubitemid 32299640)
15. Carmeli Y, Samore MH, Huskins C. The association between antecedent vancomycin treatment and hospital-Acquired vancomycin-resistant enterococci: a meta-Analysis. Arch Intern Med. 1999;159:2461-8. (Pubitemid 29526775)
16. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, 18th informational supplement M100-S18. Wayne: CLSI; 2008.
17. Rodríguez-Noriega E, Seas C. The changing pattern of methicillin-resistant Staphylococcus aureus clones in Latin America: implications for clinical practice in the region. Braz J Infect Dis. 2010;14(Suppl 2):S87-96.
18. Bell JM, Turnidge JD, SENTRY APAC. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999. Antimicrob Agents Chemother. 2002;46:879-81.
19. Goto H, Shimada K, Ikemoto H, Oguri T, Study Group on Antimicrobial Susceptibility of Pathogens Isolated from Respiratory Infections. Antimicrobial susceptibility of pathogens isolated from more than 10, 000 patients with infectious respiratory diseases: a 25-year longitudinal study. J Infect Chemother. 2009;15:347-60.
20. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280:1233-7. (Pubitemid 28469228)
21. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2000;21:455-8. (Pubitemid 30620213)
22. Burke JP. Antibiotic resistance-squeezing the balloon? JAMA. 1998;280:1270-1.
23. Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob. 2006;5:2.
24. Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother. 2003;47:3040-5. (Pubitemid 37229554)
25. Katayama Y, Murakami-Kuroda H, Cui L, Hiramatsu K. Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem. Antimicrob Agents Chemother. 2009;53: 3190-6.